As the Victorian State election will be held on Saturday 28 November 2026, the Victorian Government will assume a Caretaker role from 6pm on 3 November 2026. During the caretaker period, content will only be added to this website in accordance with the Caretaker Conventions. See Guidelines for Caretaker Conventions.
In this section
Acute meningococcal disease Meningitis and encephalitis Invasive group A streptococcal infections: management of household contacts
Contact prophylaxis for invasive meningococcal and Haemophilus influenzae type b (Hib) disease involves the treatment of at-risk contacts to eliminate nasopharyngeal carriage, thereby reducing transmission and the risk of secondary cases; it should be given to contacts as soon as possible
Antimicrobial recommendations may vary according to local antimicrobial susceptibility patterns. Refer to local guidelines
Close and prolonged contact within 7 days prior to the onset of symptoms until 24 hours after antibiotic treatment including
Ciprofloxacin PO as a single dose
Ceftriaxone is preferred in pregnancy. Rifampicin is preferred in neonates
Rifampicin is contraindicated in pregnancy and severe liver disease
Rifampicin PO BD for 2 days
Pregnancy or contraindication to Rifampicin:
Ceftriaxone IM as a single dose
The index patient if they have not been treated with ceftriaxone/cefotaxime
Close and prolonged contact within 7 days prior to the onset of symptoms until 48 hours after antibiotic treatment including
The definition of a vulnerable contact is
Rifampicin PO daily for 4 days
Pregnancy or contraindication to Rifampicin
Rifampicin pharmacological considerations
*Last updated April 2026